Heron Bay Capital Management Has $839,000 Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Heron Bay Capital Management reduced its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 2.1% during the 4th quarter, Holdings Channel reports. The institutional investor owned 1,659 shares of the healthcare conglomerate’s stock after selling 35 shares during the quarter. Heron Bay Capital Management’s holdings in UnitedHealth Group were worth $839,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. M&T Bank Corp increased its stake in UnitedHealth Group by 13.4% in the 3rd quarter. M&T Bank Corp now owns 220,590 shares of the healthcare conglomerate’s stock valued at $128,975,000 after buying an additional 26,074 shares during the last quarter. Sugarloaf Wealth Management LLC increased its stake in UnitedHealth Group by 17.6% in the 4th quarter. Sugarloaf Wealth Management LLC now owns 7,957 shares of the healthcare conglomerate’s stock valued at $4,025,000 after buying an additional 1,193 shares during the last quarter. Benjamin Edwards Inc. increased its stake in UnitedHealth Group by 1,275.3% in the 3rd quarter. Benjamin Edwards Inc. now owns 44,547 shares of the healthcare conglomerate’s stock valued at $26,060,000 after buying an additional 41,308 shares during the last quarter. Parsifal Capital Management LP acquired a new position in shares of UnitedHealth Group during the 3rd quarter worth about $21,165,000. Finally, Signal Advisors Wealth LLC increased its stake in shares of UnitedHealth Group by 13.0% during the 4th quarter. Signal Advisors Wealth LLC now owns 9,115 shares of the healthcare conglomerate’s stock worth $4,611,000 after purchasing an additional 1,051 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several research analysts have recently weighed in on the stock. Truist Financial lowered their price objective on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating on the stock in a research note on Monday, January 6th. Cantor Fitzgerald restated an “overweight” rating and set a $700.00 price objective on shares of UnitedHealth Group in a research note on Friday, January 17th. StockNews.com upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Thursday, January 23rd. Deutsche Bank Aktiengesellschaft lifted their target price on shares of UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a report on Tuesday, December 3rd. Finally, Piper Sandler reduced their target price on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a report on Thursday, January 2nd. Twenty equities research analysts have rated the stock with a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Buy” and a consensus price target of $629.32.

Insider Activity

In related news, Director Timothy Patrick Flynn bought 1,000 shares of the business’s stock in a transaction that occurred on Friday, January 17th. The shares were acquired at an average cost of $511.57 per share, with a total value of $511,570.00. Following the completion of the purchase, the director now directly owns 4,500 shares in the company, valued at $2,302,065. The trade was a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Insiders own 0.33% of the company’s stock.

UnitedHealth Group Trading Up 1.3 %

Shares of NYSE UNH opened at $517.72 on Friday. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $630.73. The firm has a 50 day moving average price of $510.19 and a two-hundred day moving average price of $547.11. The stock has a market cap of $473.57 billion, a P/E ratio of 33.40, a price-to-earnings-growth ratio of 1.37 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm had revenue of $100.81 billion during the quarter, compared to analysts’ expectations of $101.60 billion. During the same period in the prior year, the company posted $5.83 EPS. The company’s revenue was up 6.8% on a year-over-year basis. As a group, equities analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were paid a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.62%. The ex-dividend date of this dividend was Monday, March 10th. UnitedHealth Group’s dividend payout ratio is currently 54.19%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.